x

Search for a clinical trial

* (*) mandatory field

Evaluating the morphofunctional effects of eculizumab therapy in primary membranoproliferative glomerulonephritis: a pilot, single arm study in ten patients with persistent heavy proteinuria

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • IRCCS ISTITUTO DI RICERCHE FARMACOLOGICHE - MARIO NEGRI
  • Geographic coverage : National
  • Sponsor : -
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Pr Giuseppe REMUZZI
  • Centro di Ricerche Cliniche per le Malattie Rare
  • Istituto di Ricerche Farmacologiche Mario Negri
  • Via G.B. Camozzi 3
  • 24020 RANICA (BG)
  • ITALY
  • More information
  • Phone  : 39 035 4535304
  • Fax  : 39 035 4535373
  • Website
  • Contact secretary  :
Last update: November 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.